ReviewFrontiers in cellular and infection microbiology2020

Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota.

Qi-You Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.